Their studies found that BHB exhibits a glucose-lowering effect without increasing insulin, which points to the potential therapeutic benefits of exogenous ketone supplementation for individuals who have or are at risk of T2D [96]. The gene discussed is INS; the disease is type 2 diabetes mellitus.